People_

Dr Yoon-Jung Kang

Research Fellow
Sydney School of Public Health
Faculty of Medicine and Health
Research Methods Stream
The Daffodil Centre

Email

yoon-jung.kang@sydney.edu.au

Websites

The Daffodil Centre

Biographical details

Dr Yoon-Jung Kang completed a PhD in Epidemiology and has broad research experience in cancer epidemiology and cost-effectiveness evaluations in the context of cancer prevention and control. Over the last five years, Yoon has been working on Lynch syndrome, an inherited predisposition to colorectal, endometrial, and other cancers. She has led the evaluation of benefits, harms and cost-effectiveness of various testing and risk management strategies for Lynch syndrome. Further evaluations related to Lynch syndrome are in progress, including an in-depth comparison of many different surveillance approaches, and assessing the cost-effectiveness of implementation strategies to increase Lynch syndrome testing and referral practices in the health system.

Research interests

Epidemiology

Current research students

Project title	Research student
Melanoma risk assessment and risk-stratified melanoma screening and surveillance with a focus on skin imaging technologies	Gillian REYES-MARCELINO

Publications

By Type

Expand all

Journals

Lacaze, P., Marquina, C., Tiller, J., Brotchie, A., Kang, Y., Merritt, M., Green, R., Watts, G., Nowak, K., Manchanda, R., Canfell, K., et al (2023). Combined population genomic screening for three high-risk conditions in Australia: a modelling study. EClinicalMedicine, 66. [More Information]
Reyes Marcelino, G., McLoughlin, K., Harrison, C., Watts, C., Kang, Y., Aranda, S., Aitken, J., Guitera, P., Cust, A. (2023). Skin cancer-related conditions managed in general practice in Australia, 2000-2016: A nationally representative, cross-sectional survey. BMJ Open, 13(5). [More Information]
O’Haire, S., Franchini, F., Kang, Y., Steinberg, J., Canfell, K., Desai, J., Fox, S., IJzerman, M. (2023). Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours. Scientific Reports, 13(1). [More Information]
Kang, Y., O’Haire, S., Franchini, F., IJzerman, M., Zalcberg, J., MacRae, F., Canfell, K., Steinberg, J. (2022). A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours. Scientific Reports, 12(1). [More Information]
Steinberg, J., Chan, P., Hogden, E., Tiernan, G., Morrow, A., Kang, Y., He, E., Venchiarutti, R., Titterton, L., Sankey, L., Mckay, S., Engel, A., Kench, J., Solomon, M., Toh, J., Canfell, K., et al (2022). Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals. Hereditary Cancer in Clinical Practice, 20(1), 18. [More Information]
Kang, Y., Caruana, M., McLoughlin, K., Killen, J., Simms, K., Taylor, N., Frayling, I., Coupe, V., Boussioutas, A., Trainer, A., Ward, R., Canfell, K., et al (2022). The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome. Genetics in Medicine, 24(9), 1831-1846. [More Information]
Kaur, R., McDonald, C., Meiser, B., Macrae, F., Smith, S., Kang, Y., Caruana, M., Mitchell, G. (2022). The Risk-Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational Leaflet. Advanced Genetics, 3(2), 2100046. [More Information]
Tiernan, G., Freeman, V., Morrow, A., Hogden, E., Canfell, K., Kang, Y., Taylor, N. (2022). What would I do? Perspectives on the factors underlying Lynch syndrome genetic testing and results sharing decisions for high-risk colorectal cancer patients. Psycho-Oncology, 31(4), 587-596. [More Information]
Watts, C., McLoughlin, K., Goumas, C., Van Kemenade, C., Aitken, J., Soyer, H., Fernandez Penas, P., Guitera, P., Scolyer, R., Morton, R., Menzies, S., Caruana, M., Kang, Y., Mann, G., Madronio, C., Armstrong, B., Thompson, J., Cust, A., et al (2021). Association between Melanoma Detected during Routine Skin Checks and Mortality. JAMA Dermatology, 157(12), 1425-1436. [More Information]
O'Shea, R., Taylor, N., Crook, A., Jacobs, C., Kang, Y., Lewis, S., Rankin, N. (2021). Health system interventions to integrate genetic testing in routine oncology services: A systematic review. PloS One, 16, e0250379. [More Information]
Reyes Marcelino, G., Tabbakh, T., Espinoza, D., Sinclair, C., Kang, Y., McLoughlin, K., Caruana, M., Fernandez Penas, P., Guitera, P., Aitken, J., Canfell, K., Cust, A., et al (2021). Prevalence of skin examination behaviours among Australians over time. Cancer Epidemiology, 70, 101874. [More Information]
Morrow, A., Parkinson, B., Kang, Y., Hogden, E., Canfell, K., Taylor, N. (2020). The health and economic impact of implementation strategies for improving detection of hereditary cancer patients - protocol for an in-depth cost-effectiveness evaluation with microsimulation modelling. Implementation Science Communications, 1(1), 70. [More Information]
Weber, M., Marshall, H., Rankin, N., Duffy, S., Fong, K., Dunlop, K., Humphreys, L., Smit, A., Cust, A., Taylor, N., Kang, Y., Armstrong, B., et al (2019). Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers. Public Health Research and Practice, 29(2), 1-9. [More Information]
Morrow, A., Hogden, E., Kang, Y., Steinberg, J., Canfell, K., Solomon, M., Kench, J., Gill, A., Shaw, T., Pachter, N., Taylor, N., et al (2019). Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol. Trials, 20(1), 1-12. [More Information]
Barlow, E., Kang, Y., Hacker, N., Canfell, K. (2015). Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia since 1982. International Journal of Gynecological Cancer, 25(9), 1683-1689. [More Information]
Kang, Y., O'Connell, D., Tan, J., Lew, J., Demers, A., Lotocki, R., Kliewer, E., Hacker, N., Jackson, M., Delaney, G., et al (2015). Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities. Cancer Epidemiology, 39(4), 600-611. [More Information]
Shi, J., Canfell, K., Lew, J., Zhao, F., Legood, R., Ning, Y., Simonella, L., Ma, L., Kang, Y., Zhang, Y., et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11(239), 1-18. [More Information]
Canfell, K., Banks, E., Kang, Y., Moa, A., Armstrong, B., Beral, V. (2009). Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003. Breast Cancer Research and Treatment, 117, 671-3. [More Information]
Canfell, K., Kang, Y., Clements, M., Moa, A., Beral, V. (2008). Normal endometrial cells in cervical cytology: systematic review of prevalence and relation to significant endometrial pathology. Journal of Medical Screening, 15(4), 188-198. [More Information]

show 16 more

By Year

Expand all

2023

Lacaze, P., Marquina, C., Tiller, J., Brotchie, A., Kang, Y., Merritt, M., Green, R., Watts, G., Nowak, K., Manchanda, R., Canfell, K., et al (2023). Combined population genomic screening for three high-risk conditions in Australia: a modelling study. EClinicalMedicine, 66. [More Information]
Reyes Marcelino, G., McLoughlin, K., Harrison, C., Watts, C., Kang, Y., Aranda, S., Aitken, J., Guitera, P., Cust, A. (2023). Skin cancer-related conditions managed in general practice in Australia, 2000-2016: A nationally representative, cross-sectional survey. BMJ Open, 13(5). [More Information]
O’Haire, S., Franchini, F., Kang, Y., Steinberg, J., Canfell, K., Desai, J., Fox, S., IJzerman, M. (2023). Systematic review of NTRK 1/2/3 fusion prevalence pan-cancer and across solid tumours. Scientific Reports, 13(1). [More Information]

2022

Kang, Y., O’Haire, S., Franchini, F., IJzerman, M., Zalcberg, J., MacRae, F., Canfell, K., Steinberg, J. (2022). A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours. Scientific Reports, 12(1). [More Information]
Steinberg, J., Chan, P., Hogden, E., Tiernan, G., Morrow, A., Kang, Y., He, E., Venchiarutti, R., Titterton, L., Sankey, L., Mckay, S., Engel, A., Kench, J., Solomon, M., Toh, J., Canfell, K., et al (2022). Lynch syndrome testing of colorectal cancer patients in a high-income country with universal healthcare: a retrospective study of current practice and gaps in seven australian hospitals. Hereditary Cancer in Clinical Practice, 20(1), 18. [More Information]
Kang, Y., Caruana, M., McLoughlin, K., Killen, J., Simms, K., Taylor, N., Frayling, I., Coupe, V., Boussioutas, A., Trainer, A., Ward, R., Canfell, K., et al (2022). The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome. Genetics in Medicine, 24(9), 1831-1846. [More Information]
Kaur, R., McDonald, C., Meiser, B., Macrae, F., Smith, S., Kang, Y., Caruana, M., Mitchell, G. (2022). The Risk-Reducing Effect of Aspirin in Lynch Syndrome Carriers: Development and Evaluation of an Educational Leaflet. Advanced Genetics, 3(2), 2100046. [More Information]
Tiernan, G., Freeman, V., Morrow, A., Hogden, E., Canfell, K., Kang, Y., Taylor, N. (2022). What would I do? Perspectives on the factors underlying Lynch syndrome genetic testing and results sharing decisions for high-risk colorectal cancer patients. Psycho-Oncology, 31(4), 587-596. [More Information]

show 2 more

2021

Watts, C., McLoughlin, K., Goumas, C., Van Kemenade, C., Aitken, J., Soyer, H., Fernandez Penas, P., Guitera, P., Scolyer, R., Morton, R., Menzies, S., Caruana, M., Kang, Y., Mann, G., Madronio, C., Armstrong, B., Thompson, J., Cust, A., et al (2021). Association between Melanoma Detected during Routine Skin Checks and Mortality. JAMA Dermatology, 157(12), 1425-1436. [More Information]
O'Shea, R., Taylor, N., Crook, A., Jacobs, C., Kang, Y., Lewis, S., Rankin, N. (2021). Health system interventions to integrate genetic testing in routine oncology services: A systematic review. PloS One, 16, e0250379. [More Information]
Reyes Marcelino, G., Tabbakh, T., Espinoza, D., Sinclair, C., Kang, Y., McLoughlin, K., Caruana, M., Fernandez Penas, P., Guitera, P., Aitken, J., Canfell, K., Cust, A., et al (2021). Prevalence of skin examination behaviours among Australians over time. Cancer Epidemiology, 70, 101874. [More Information]

2020

Morrow, A., Parkinson, B., Kang, Y., Hogden, E., Canfell, K., Taylor, N. (2020). The health and economic impact of implementation strategies for improving detection of hereditary cancer patients - protocol for an in-depth cost-effectiveness evaluation with microsimulation modelling. Implementation Science Communications, 1(1), 70. [More Information]

2019

Weber, M., Marshall, H., Rankin, N., Duffy, S., Fong, K., Dunlop, K., Humphreys, L., Smit, A., Cust, A., Taylor, N., Kang, Y., Armstrong, B., et al (2019). Cancer screening in Australia: future directions in melanoma, Lynch syndrome, and liver, lung and prostate cancers. Public Health Research and Practice, 29(2), 1-9. [More Information]
Morrow, A., Hogden, E., Kang, Y., Steinberg, J., Canfell, K., Solomon, M., Kench, J., Gill, A., Shaw, T., Pachter, N., Taylor, N., et al (2019). Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol. Trials, 20(1), 1-12. [More Information]

2015

Barlow, E., Kang, Y., Hacker, N., Canfell, K. (2015). Changing Trends in Vulvar Cancer Incidence and Mortality Rates in Australia since 1982. International Journal of Gynecological Cancer, 25(9), 1683-1689. [More Information]
Kang, Y., O'Connell, D., Tan, J., Lew, J., Demers, A., Lotocki, R., Kliewer, E., Hacker, N., Jackson, M., Delaney, G., et al (2015). Optimal uptake rates for initial treatments for cervical cancer in concordance with guidelines in Australia and Canada: Results from two large cancer facilities. Cancer Epidemiology, 39(4), 600-611. [More Information]

2011

Shi, J., Canfell, K., Lew, J., Zhao, F., Legood, R., Ning, Y., Simonella, L., Ma, L., Kang, Y., Zhang, Y., et al (2011). Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study. BMC Cancer, 11(239), 1-18. [More Information]

2009

Canfell, K., Banks, E., Kang, Y., Moa, A., Armstrong, B., Beral, V. (2009). Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003. Breast Cancer Research and Treatment, 117, 671-3. [More Information]

2008

Canfell, K., Kang, Y., Clements, M., Moa, A., Beral, V. (2008). Normal endometrial cells in cervical cytology: systematic review of prevalence and relation to significant endometrial pathology. Journal of Medical Screening, 15(4), 188-198. [More Information]

Page not found

Dr Yoon-Jung Kang

Publications

By Type

By Year